Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Danjing Luo, Qiulu Zhong & Xiaodong Zhu. (2023) The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis. Cancer Biology & Therapy 24:1.
Read now
Read now
Chen Li, Xin Wang, Lan Wang, Junqiang Chen, Wencheng Zhang, Qingsong Pang, Yidian Zhao, Xinchen Sun, Kaixian Zhang, Gaofeng Li, Ling Li, Xueying Qiao, Miaoling Liu, Yadi Wang, Lei Deng, Wenqing Wang, Nan Bi, Tao Zhang, Wei Deng, Wenjie Ni, Xiao Chang, Weiming Han, Zongmei Zhou, Jun Liang, Qinfu Feng, Lvhua Wang, Dongfu Chen, Jima Lv, Shuchai Zhu, Chun Han & Zefen Xiao. (2021) Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG Survey. Acta Oncologica 60:5, pages 627-634.
Read now
Read now
Yijun Luo, Qingfeng Mao, Xiaoli Wang, Jinming Yu & Minghuan Li. (2018) Radiotherapy for esophageal carcinoma: dose, response and survival. Cancer Management and Research 10, pages 13-21.
Read now
Read now
Shiliang Lv, Min Fang, Jia Yang, Wenming Zhan, Yongshi Jia, Hong’en Xu & Tao Song. (2016) Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer. OncoTargets and Therapy 9, pages 5389-5397.
Read now
Read now
Articles from other publishers (33)
Marieke Pape, Linde M. Veen, Thom M. Smit, Steven C. Kuijper, Pauline A.J. Vissers, Elisabeth D. Geijsen, Peter S.N. van Rossum, Mirjam A.G. Sprangers, Sarah Derks, Rob H.A. Verhoeven & Hanneke W.M. van Laarhoven. (2023) Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysis. International Journal of Radiation Oncology*Biology*Physics 117:1, pages 31-44.
Crossref
Crossref
Julian Mangesius, Katharina Hörmandinger, Robert Jäger, Sergej Skvortsov, Marlen Plankensteiner, Martin Maffei, Thomas Seppi, Daniel Dejaco, Matthias Santer, Manuel Sarcletti & Ute Ganswindt. (2023) Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma. Cancers 15:14, pages 3594.
Crossref
Crossref
Fangjie Chen, Ying Wu, Hong’en Xu, Tao Song & Senxiang Yan. (2022) Impact of marital status on overall survival in patients with early-stage hepatocellular carcinoma. Scientific Reports 12:1.
Crossref
Crossref
Yujin Xu, Baiqiang Dong, Weiguo Zhu, Jiancheng Li, Rong Huang, Zongwen Sun, Xinmei Yang, Liping Liu, Han He, Zhongxing Liao, Ni Guan, Yue Kong, Wanwei Wang, Jianxiang Chen, Huijuan He, Guoqin Qiu, Ming Zeng, Juan Pu, Wangyuan Hu, Yong Bao, Zhigang Liu, Jun Ma, Hao Jiang, Xianghui Du, Jin Hu, Tingting Zhuang, Jing Cai, Jin Huang, Hua Tao, Yuan Liu, Xiaodong Liang, Juying Zhou, Guangzhou Tao, Xiao Zheng & Ming Chen. (2022) A Phase III Multicenter Randomized Clinical Trial of 60 Gy versus 50 Gy Radiation Dose in Concurrent Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma. Clinical Cancer Research 28:9, pages 1792-1799.
Crossref
Crossref
Li-Qing Li, Qing-Guo Fu, Wei-Dong Zhao, Yu-Dan Wang, Wan-Wan Meng & Ting-Shi Su. (2022) Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting. Frontiers in Oncology 12.
Crossref
Crossref
Suresh Raghunath, Richa Tiwari, S Rashmi, SN Geetha, Raahin Sulthana & Irappa Madabhavi. (2022) Impact of radical dose escalation by endoluminal brachytherapy and induction chemotherapy in the definitive treatment of locally advanced esophageal cancer - A retrospective study. Journal of Cancer Research and Therapeutics 18:9, pages 280.
Crossref
Crossref
Sarbani Ghosh-Laskar, Naveen Mummudi, Saurabha Kumar, Mukesh Chandre, Shagun Mishra, Anil Tibdewal, JaiPraklash Agarwal, Vijay Patil, Vanita Noronha, Kumar Prabash, Prachi Patil, Sabita Jiwnani, George Karimundackal & CS Pramesh. (2022) Definitive radiation therapy with dose escalation is beneficial for patients with squamous cell cancer of the esophagus. Journal of Cancer Research and Therapeutics 18:9, pages 285.
Crossref
Crossref
Lin-Rui Gao, Chen Li, Weiming Han, Wenjie Ni, Wei Deng, Lijun Tan, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Wenqing Wang, Wenyang Liu, Lei Deng, Xin Wang, Tao Zhang, Jianyang Wang, Yirui Zhai, Nan Bi, Lvhua Wang, Zhouguang Hui, Ye-Xiong Li & Zefen Xiao. (2022) Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy. Therapeutic Advances in Medical Oncology 14, pages 175883592211086.
Crossref
Crossref
Huiping Zhu, Xiaoling Lu, Jian Jiang, Jingfeng Lu, Xinchen Sun & Yun Zuo. (2022) Radiotherapy Combined With Concurrent Nedaplatin-Based Chemotherapy for Stage II–III Esophageal Squamous Cell Carcinoma. Dose-Response 20:1, pages 155932582210767.
Crossref
Crossref
Maarten C. C. M. Hulshof, Elisabeth D. Geijsen, Tom Rozema, Vera Oppedijk, Jeroen Buijsen, Karen J. Neelis, Joost J. M. E. Nuyttens, Maurice J. C. van der Sangen, Paul M. Jeene, Jannie G. Reinders, Mark I. van Berge Henegouwen, Adriana Thano, Jeanin E. van Hooft, Hanneke W. M. van Laarhoven & Ate van der Gaast. (2021) Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study). Journal of Clinical Oncology 39:25, pages 2816-2824.
Crossref
Crossref
Chen Li, Lijun Tan, Xiao Liu, Xin Wang, Zongmei Zhou, Dongfu Chen, Qinfu Feng, Jun Liang, Jima Lv, Xiaozhen Wang, Nan Bi, Lei Deng, Wenqing Wang, Tao Zhang, Wenjie Ni, Xiao Chang, Weiming Han, Linrui Gao, Shijia Wang & Zefen Xiao. (2021) Concurrent chemoradiotherapy versus radiotherapy alone for patients with locally advanced esophageal squamous cell carcinoma in the era of intensity modulated radiotherapy: a propensity score‐matched analysis. Thoracic Cancer 12:12, pages 1831-1840.
Crossref
Crossref
Takashi Ono. (2020) Review of clinical results of charged-particle therapy for esophageal cancer. Esophagus 18:1, pages 33-40.
Crossref
Crossref
Lin-rui Gao, Xin Wang, Weiming Han, Wei Deng, Chen Li, Xiaomin Wang, Yidian Zhao, Wenjie Ni, Xiao Chang, Zongmei Zhou, Lei Deng, Wenqing Wang, Wenyang Liu, Jun Liang, Tao Zhang, Nan Bi, Jianyang Wang, Yirui Zhai, Qinfu Feng, Jima Lv, Ling Li & Zefen Xiao. (2020) A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol. BMC Cancer 20:1.
Crossref
Crossref
Xin Sun, Lei Wang, Yang Wang, Jingjing Kang, Wei Jiang, Yu Men & Zhouguang Hui. (2020) High vs. Low Radiation Dose of Concurrent Chemoradiotherapy for Esophageal Carcinoma With Modern Radiotherapy Techniques: A Meta-Analysis. Frontiers in Oncology 10.
Crossref
Crossref
Dora L. W. Kwong, Wendy W. L. Chan & Ka On Lam. 2020. Esophageal Squamous Cell Carcinoma. Esophageal Squamous Cell Carcinoma
295
305
.
He-San Luo, He-Cheng Huang & Lian-Xing Lin. (2019) Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis. Radiation Oncology 14:1.
Crossref
Crossref
Chen Li, Wenjie Ni, Xin Wang, Zongmei Zhou, Wei Deng, Xiao Chang, Dongfu Chen, Qinfu Feng, Jun Liang, Xiaozhen Wang, Lei Deng, Wenqing Wang, Nan Bi, Tao Zhang & Zefen Xiao. (2019) A phase I/II radiation dose escalation trial using simultaneous integrated boost technique with elective nodal irradiation and concurrent chemotherapy for unresectable esophageal Cancer. Radiation Oncology 14:1.
Crossref
Crossref
Chen Li, Xiaomin Wang, Xin Wang, Chun Han, Ping Wang, Qingsong Pang, Junqiang Chen, Xinchen Sun, Lan Wang, Wencheng Zhang, Yu Lin, Xiaolin Ge, Zongmei Zhou, Wenjie Ni, Xiao Chang, Jun Liang, Lei Deng, Wenqing Wang, Yidian Zhao & Zefen Xiao. (2019) A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer – the 3JECROG P-01 study protocol. BMC Cancer 19:1.
Crossref
Crossref
Tae Ryong Chung, Jie-Hyun Kim, Ik Jae Lee, Yeona Cho, Jun Won Kim, Chang Geol Lee, Da Hyun Jung, Jae Jun Park, Young Hoon Youn & Hyojin Park. (2019) Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement. Digestive and Liver Disease 51:11, pages 1610-1616.
Crossref
Crossref
Rajneesh Kumar Singh. 2019. GI Surgery Annual. GI Surgery Annual
1
62
.
Xuejiao Ren, Lan Wang, Chun Han & Leiming Ren. (2018) Retrospective analysis of safety profile of high-dose concurrent chemoradiotherapy for patients with oesophageal squamous cell carcinoma. Radiotherapy and Oncology 129:2, pages 293-299.
Crossref
Crossref
Paul M. Jeene, Hanneke W.M. van Laarhoven & Maarten C.C.M. Hulshof. (2018) The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer. Best Practice & Research Clinical Gastroenterology 36-37, pages 53-59.
Crossref
Crossref
Chao-Yueh Fan, Yu-Fu Su, Wen-Yen Huang, Hsing-Lung Chao, Kuen-Tze Lin & Chun-Shu Lin. (2018) Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer. Scientific Reports 8:1.
Crossref
Crossref
Hidekazu Hirano & Narikazu Boku. (2018) The current status of multimodality treatment for unresectable locally advanced esophageal squamous cell carcinoma. Asia-Pacific Journal of Clinical Oncology 14:4, pages 291-299.
Crossref
Crossref
Peter S. N. van Rossum, Nadia Haj Mohammad, Frank P. Vleggaar & Richard van Hillegersberg. (2017) Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends. Nature Reviews Gastroenterology & Hepatology 15:4, pages 235-249.
Crossref
Crossref
Huaijun Ji, Ming Cao, Kunlun Ren, Ningbo Sun, Wei Wang, Qiang Zhu, Qi Zang & Zhongmin Jiang. (2017) Expression and Clinicopathological Significance of Mel-18 and Bmi-1 in Esophageal Squamous Cell Carcinoma. Technology in Cancer Research & Treatment 16:6, pages 828-834.
Crossref
Crossref
Yong Chen, Hui-Ping Zhu, Tao Wang, Chang-Jiang Sun, Xiao-Lin Ge, Ling-Feng Min, Xian-Wen Zhang, Qing-Qing Jia, Jie Yu, Jian-Qi Yang, Heike Allgayer, Mohammed L. Abba, Xi-Zhi Zhang & Xin-Chen Sun. (2017) What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis. Oncotarget 8:51, pages 89095-89107.
Crossref
Crossref
Zhao Jing, Tian Chen, Xuebang Zhang & Shixiu Wu. (2017) Long‐term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer. Cancer Science 108:9, pages 1828-1833.
Crossref
Crossref
Hyun Ju Kim, Yang-Gun Suh, Yong Chan Lee, Sang Kil Lee, Sung Kwan Shin, Byung Chul Cho & Chang Geol Lee. (2017) Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy. Cancer Research and Treatment 49:3, pages 669-677.
Crossref
Crossref
Ming-Qiu Chen, Qing-Liang Lin, Yuan-Gui Chen, Jin-Hua Guo, Ben-Hua Xu & Ye Tian. (2017) Neoadjuvant chemotherapy may not benefit esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy. Journal of the Chinese Medical Association.
Crossref
Crossref
Ruzhen Zheng, Yuehua Liu, Xiaoling Zhang, Pengjun Zhao & Qinghua Deng. (2017) miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21. Biomedicine & Pharmacotherapy 90, pages 517-523.
Crossref
Crossref
B. De, R. Rhome, J. Doucette & M. Buckstein. (2017) Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis. Diseases of the Esophagus 30:4, pages 1-10.
Crossref
Crossref
Tao Song, Xuebang Zhang, Min Fang, Ruping Zhao & Shixiu Wu. (2016) Long-term results of definitive concurrent chemoradiotherapy using paclitaxel plus oxaliplatin in unresectable locally advanced esophageal cancer: a prospective phase II trial. Cancer Medicine 5:12, pages 3371-3377.
Crossref
Crossref